France's bioMerieux Offers Product To Detect E. sakazakii
Laboratorytalk, which bills itself as the lab equipment news source, reports that a company called bioMerieux is launching an “innovative chromogenic culture media—ChromID Sakazakii—for “precise, reliable controls” of Enterobacter sakazakii.
Here are the money quotes from the Laboratorytalk report:
Enterobacter sakazakii is considered to be a neonatal pathogen Its presence in infant food products, including powdered milk, can cause meningitis, sepsis and other serious infections, primarily in newborn or premature infants.
40 to 80 percent of children who become infected die, and those who survive can suffer severe and long-lasting complications.
Its innovative formula reveals two Enterobacter sakazakii-specific enzyme activities that offer a high level of detection sensitivity in just 24 hours of incubation.
Enterobacter sakazakii is an enterobacterium that is naturally present in the environment and can be found in various foods, most notably dehydrated products. Considered a neonatal pathogen, when present in infant food products, it can cause serious infections such as neonatal meningitis or necrotizing enterocolitis, as well as the deaths of 40 to 80 percent of children infected.
A French company involved vitro diagnostics for 45 years, bioMérieux is present in more than 150 countries through 38 subsidiaries and a large network of distributors. In 2007, revenues reached €1.063 billion with 84 percent of sales outside of France.
For story, Innovative ways to detect food-borne pathogens, go here.
